Stephen R Brady is President and CEO of Tempest Therapeutics Inc.
Person profile
Roles
Tempest Therapeutics
President and CEO
Atreca Inc - Ordinary Shares
Director
Address
Seattle, Washington
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Tempest Therapeutics, Inc.
5 Jan 24
4
Tempest Therapeutics, Inc.
13 Oct 23
4
Atreca, Inc.
15 Jun 23
4
Tempest Therapeutics, Inc.
5 Jan 23
4
Tempest Therapeutics, Inc.
22 Jun 22
4
Atreca, Inc.
10 Jun 22
4
Tempest Therapeutics, Inc.
6 Jan 22
4
Atreca, Inc.
16 Jul 21
3
Atreca, Inc.
16 Jul 21
4
Millendo Therapeutics, Inc.
29 Jun 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Jan 24 | TPST Tempest Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 4.66 | 250,000 | 1.17 mm | 250,000 |
11 Oct 23 | TPST Tempest Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 9.77 | 725,000 | 7.08 mm | 725,000 |
13 Jun 23 | BCEL Atreca Inc - Ordinary Shares | Stock Option Class A Common Stock | Grant | Acquire A | No | No | 1.18 | 12,000 | 14.16 k | 12,000 |
3 Jan 23 | TPST Tempest Therapeutics | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 1.23 | 177,300 | 218.08 k | 177,300 |